Cargando…
Effects of Bempedoic Acid in Acute Myocardial Infarction in Rats: No Cardioprotection and No Hidden Cardiotoxicity
Lipid-lowering drugs have been shown to have cardioprotective effects but may have hidden cardiotoxic properties. Therefore, here we aimed to investigate if chronic treatment with the novel lipid-lowering drug bempedoic acid (BA) exerts hidden cardiotoxic and/or cardioprotective effects in a rat mod...
Autores principales: | Gergely, Tamás G., Brenner, Gábor B., Nagy, Regina N., Sayour, Nabil V., Makkos, András, Kovácsházi, Csenger, Tian, Huimin, Schulz, Rainer, Giricz, Zoltán, Görbe, Anikó, Ferdinandy, Péter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860765/ https://www.ncbi.nlm.nih.gov/pubmed/36675100 http://dx.doi.org/10.3390/ijms24021585 |
Ejemplares similares
-
Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In Vivo
por: Weber, Bennet Y., et al.
Publicado: (2022) -
Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion
por: Brenner, Gábor B., et al.
Publicado: (2020) -
Cardioprotective efficacy of limb remote ischaemic preconditioning in rats: discrepancy between a meta-analysis and a three-centre in vivo study
por: Sayour, Nabil V, et al.
Publicado: (2023) -
Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications
por: Ferdinandy, Péter, et al.
Publicado: (2019) -
Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
por: Vörös, Imre, et al.
Publicado: (2021)